Bronte Capital Management’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-154,878
| Closed | -$596K | – | 36 |
|
2023
Q2 | $596K | Sell |
154,878
-2,577
| -2% | -$9.92K | 0.06% | 32 |
|
2023
Q1 | $476K | Sell |
157,455
-1,950
| -1% | -$5.89K | 0.06% | 30 |
|
2022
Q4 | $327K | Sell |
159,405
-4,142
| -3% | -$8.5K | 0.04% | 27 |
|
2022
Q3 | $566K | Hold |
163,547
| – | – | 0.07% | 28 |
|
2022
Q2 | $689K | Buy |
163,547
+323
| +0.2% | +$1.36K | 0.08% | 30 |
|
2022
Q1 | $496K | Buy |
163,224
+6,008
| +4% | +$18.3K | 0.04% | 28 |
|
2021
Q4 | $731K | Sell |
157,216
-2,246
| -1% | -$10.4K | 0.05% | 24 |
|
2021
Q3 | $1.23M | Hold |
159,462
| – | – | 0.09% | 23 |
|
2021
Q2 | $1.37M | Buy |
+159,462
| New | +$1.37M | 0.1% | 17 |
|